Stocktoria
Sana Biotechnology, Inc. SANA
Nasdaq · stock · Biological Products, (No Diagnostic Substances) · website · IPO 2021-02-04
Sana Biotechnology, Inc. institutional holders
| Investor | Shares | Value | % of company |
|---|---|---|---|
| BlackRock Finance, Inc. | 11,045,448 | $60.3M | 4.14% |
| RENAISSANCE TECHNOLOGIES LLC | 1,231,100 | $4.3M | 0.46% |
| AQR CAPITAL MANAGEMENT LLC | 963,147 | $3.4M | 0.36% |
| MILLENNIUM MANAGEMENT LLC | 653,503 | $2.3M | 0.25% |
| TWO SIGMA INVESTMENTS, LP | 638,837 | $2.2M | 0.24% |
| Point72 Asset Management, L.P. | 595,091 | $2.1M | 0.22% |
| CITADEL ADVISORS LLC | 341,878 | $1.2M | 0.13% |
| D. E. Shaw & Co., Inc. | 40,090 | $139,914 | 0.02% |
% of company = reported institutional shares ÷ shares outstanding. Based on the latest reports; not every holder reports every quarter.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.